Remodulin 2.5 (Treprostinil Vials) 2.5mg/ml x 20ml

Remodulin 2.5 (Treprostinil) 2.5mg/ml x 20ml vials are a prostacyclin vasodilator used to manage pulmonary arterial hypertension. This formulation supports consistent dosing for continuous subcutaneous or intravenous therapy. Ideal for patients requiring long-term vascular support.

Strength

2.5mg/ml x 20ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Ferrer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Treprostinil is used to treat pulmonary arterial hypertension, a condition characterized by high blood pressure in the lungs. It helps improve exercise capacity and reduce symptoms like shortness of breath. The medication works by relaxing blood vessels to enhance blood flow. Patients often use it as part of a broader treatment plan.

Side Effects

Remodulin 2.5 may cause mild to moderate side effects such as headache, flushing, or nausea. Some users report dizziness or jaw pain, which are typically temporary. These effects often lessen as the body adjusts to the medication. Staying hydrated and following dosing instructions can help minimize discomfort.

Precautions & Warnings

Store Remodulin 2.5 at room temperature away from moisture and heat. Keep the vial tightly sealed when not in use to maintain potency. Avoid freezing or exposing the medication to extreme temperatures. Always check the solution for particles or discoloration before use.

Avoid Interactions

Treprostinil may interact with blood pressure medications, diuretics, or other vasodilators. Combining it with alcohol or certain herbal supplements could intensify side effects like dizziness. Inform your healthcare provider about all medications and supplements you’re taking. Monitor for unusual symptoms when starting new treatments.

Frequently Asked Questions

Remodulin 2.5 (Treprostinil) is used to treat pulmonary arterial hypertension by improving blood flow and reducing symptoms.

Store Remodulin 2.5 at room temperature, away from heat and moisture, and keep the vial tightly sealed.

Consult your healthcare provider before combining Remodulin 2.5 with other medications, as interactions may occur.

Common side effects include headache, flushing, nausea, and dizziness, which often lessen over time.

No, Remodulin 2.5 requires a prescription and should only be used under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.